GH Research PLC
GHRS
Jodie situation report
GH Research PLC's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 20 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- GHRS's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if GHRS's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind GHRS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
CMPSCOMPASS Pathways Plc - AmericancompetitorMar 24, 2026 ▾
“We are aware that Supernus Pharmaceuticals, Neurocrine Biosciences, GH Research and Beckley Psytech, among others, are developing treatments for TRD or inadequate response to treatment in major depressive disorder.”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
GHRS is currently a Follower in the organic co-movement group Healthcare Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for GHRS; it is not active in the latest market snapshot.